{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:21:42Z","timestamp":1794471702753,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"National Institute for Health Research Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000762","name":"Imperial College Healthcare NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejca.2026.116795","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:36:22Z","timestamp":1779492982000},"page":"116795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of concurrent colonic CMV infection on clinical outcomes in immune checkpoint inhibitor\u2013induced colitis"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-2547","authenticated-orcid":false,"given":"Hajir","family":"Ibraheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-2953","authenticated-orcid":false,"given":"Paolo Davide","family":"d\u2019Arienzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan James","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Duggleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thubeena","family":"Manickavasagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-1858","authenticated-orcid":false,"given":"Foteini","family":"Kalofonou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Aboulela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree","family":"Vadera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty Ellen","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Muehlschlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0858-2621","authenticated-orcid":false,"given":"Stephanie","family":"Mullings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake James","family":"Symington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-180X","authenticated-orcid":false,"given":"Sabeera","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna Saad","family":"Hafidh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-4519","authenticated-orcid":false,"given":"Robert","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-327X","authenticated-orcid":false,"given":"James","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Clare","family":"Olsson-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejca.2026.116795_bib1","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant Nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejca.2026.116795_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejca.2026.116795_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","article-title":"Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma","volume":"24","author":"Amaria","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2026.116795_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ctrv.2017.05.003","article-title":"Combined immune checkpoint blockade (anti-PD-1\/anti-CTLA-4): evaluation and management of adverse drug reactions","volume":"57","author":"Hassel","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"10.1016\/j.ejca.2026.116795_bib5","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/annonc\/mdx286","article-title":"Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review","volume":"28","author":"Khoja","year":"2017","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.ejca.2026.116795_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejca.2026.116795_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2468-1253(20)30014-5","article-title":"British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis","volume":"5","author":"Powell","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116795_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1053\/j.gastro.2021.06.025","article-title":"Interferon-Gamma-Producing CD8+ tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor-colitis","volume":"161","author":"Sasson","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ejca.2026.116795_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ccell.2024.04.010","article-title":"Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis","volume":"42","author":"Gupta","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ejca.2026.116795_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.19.01674","article-title":"Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease","volume":"38","author":"Abu-Sbeih","year":"2020","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.ejca.2026.116795_bib11","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/s41467-023-44512-4","article-title":"Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis","volume":"15","author":"Middha","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ejca.2026.116795_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"issue":"11","key":"10.1016\/j.ejca.2026.116795_bib13","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1038\/ajg.2011.202","article-title":"Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in Ulcerative Colitis","volume":"106","author":"Roblin","year":"2011","journal-title":"J Am Coll Gastroenterol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116795_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/modpathol.2017.149","article-title":"Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease","volume":"31","author":"Wethkamp","year":"2018","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116795_bib15","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1097\/MIB.0000000000000958","article-title":"Toward an algorithm for the diagnosis and management of CMV in Patients with Colitis","volume":"22","author":"Beswick","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.ejca.2026.116795_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J Crohn\u2019S Colitis"},{"issue":"6","key":"10.1016\/j.ejca.2026.116795_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5009\/gnl13427","article-title":"Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study","volume":"8","author":"Kim","year":"2014","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.ejca.2026.116795_bib18","first-page":"230","article-title":"Cytomegalovirus complicating inflammatory bowel disease","volume":"8","author":"Al-Zafiri","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"3","key":"10.1016\/j.ejca.2026.116795_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00384-018-3210-8","article-title":"The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic","volume":"34","author":"Schenk","year":"2019","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"10.1016\/j.ejca.2026.116795_bib20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00384-020-03536-8","article-title":"Cytomegalovirus infection is associated with worse outcomes in inflammatory bowel disease hospitalizations nationwide","volume":"35","author":"Hendler","year":"2020","journal-title":"Int J Colorectal Dis"},{"issue":"11","key":"10.1016\/j.ejca.2026.116795_bib21","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1097\/MIB.0000000000000489","article-title":"Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis","volume":"21","author":"Shukla","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.ejca.2026.116795_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010081","article-title":"Impact of infections in patients receiving pembrolizumab-based therapies for non-small cell lung cancer","volume":"15","author":"Burns","year":"2023","journal-title":"Cancers"},{"issue":"8_","key":"10.1016\/j.ejca.2026.116795_bib23","article-title":"Infections in patients receiving immune checkpoint inhibitors","volume":"37","author":"Sae-Tia","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.ejca.2026.116795_bib24","article-title":"Immune checkpoint inhibitor-induced gastrointestinal injury: prevalence of cytomegalovirus, adenovirus and Epstein-Barr virus","author":"Chornenkyy","year":"2024","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejca.2026.116795_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejca.2017.09.019","article-title":"Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis","volume":"86","author":"Franklin","year":"2017","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2026.116795_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00384-017-2752-5","article-title":"Cytomegalovirus, inflammatory bowel disease, and anti-TNF\u03b1","volume":"32","author":"Campos","year":"2017","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"10.1016\/j.ejca.2026.116795_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2008.06.002","article-title":"Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy","volume":"43","author":"D\u2019Ovidio","year":"2008","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116795_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41416-020-0882-y","article-title":"Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?","volume":"123","author":"Cheung","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116795_bib29","article-title":"Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management","volume":"3","author":"Foppen","year":"2018","journal-title":"Esmo Open"},{"issue":"7","key":"10.1016\/j.ejca.2026.116795_bib30","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/s41591-025-03647-1","article-title":"CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade","volume":"31","author":"Milotay","year":"2025","journal-title":"Nat Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:56:19Z","timestamp":1785905779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926005769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S0959804926005769"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116795","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of concurrent colonic CMV infection on clinical outcomes in immune checkpoint inhibitor\u2013induced colitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116795"}}